计算机断层结肠镜检查比结肠镜检查更便宜的结肠直肠癌筛查商业保险患者。

IF 1.4 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
American Health and Drug Benefits Pub Date : 2018-10-01
Tia Goss Sawhney, Bruce S Pyenson, David Rotter, Michele Berrios, Judy Yee
{"title":"计算机断层结肠镜检查比结肠镜检查更便宜的结肠直肠癌筛查商业保险患者。","authors":"Tia Goss Sawhney,&nbsp;Bruce S Pyenson,&nbsp;David Rotter,&nbsp;Michele Berrios,&nbsp;Judy Yee","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Computed tomography (CT) colonography's effectiveness, its associated patient advantages, and its potential role to increase colorectal cancer (CRC) screening rates have been demonstrated in previous research, but whether CT colonography has a cost advantage relative to optical colonoscopy for the commercially insured US population has not been assessed.</p><p><strong>Objective: </strong>To compare the costs of CRC screening using CT colonography or optical colonoscopy for commercially insured people in the United States.</p><p><strong>Methods: </strong>Using retrospective commercial healthcare claims data and peer-reviewed studies, we performed a simulated multiyear, matched-case comparison of the costs of CT and optical colonoscopies for CRC screening. We estimated commercial optical colonoscopy costs per screening based on the 2016 Truven Health MarketScan Commercial Database and ancillary services, such as bowel preparation, anesthesia, pathology, and complication costs. We developed 4 scenarios for CT colonography cost per screening using the ratio of commercial to Medicare fees, and calculated ancillary service and follow-up costs from payers' costs for these services when associated with optical colonoscopies. For comparison, we converted the costs per screening to the costs per screening year per person using real-world screening intervals that were obtained from peer-reviewed studies.</p><p><strong>Results: </strong>In 2016, the average optical colonoscopy screening cost for commercial payers was $2033 (N = 406,068), or $340 per screening year per person. With our highest-cost CT colonography scenario, CT colonography costs 22% less, or $265 per screening year, than optical colonoscopy, mostly because of the advantages for patients of no anesthesia and the greatly reduced use of pathology services.</p><p><strong>Conclusions: </strong>The use of CT colonography for CRC testing offers effective screening, patient-centered advantages, and lower costs compared with optical colonoscopy, and may be particularly appealing to the currently unscreened population with commercial health insurance. If the availability of CT colonography expands to meet the increased demand for it, CT colonography could cost up to 50% less than optical colonoscopy per screening year.</p>","PeriodicalId":48595,"journal":{"name":"American Health and Drug Benefits","volume":"11 7","pages":"353-361"},"PeriodicalIF":1.4000,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306102/pdf/ahdb-11-353.pdf","citationCount":"0","resultStr":"{\"title\":\"Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients.\",\"authors\":\"Tia Goss Sawhney,&nbsp;Bruce S Pyenson,&nbsp;David Rotter,&nbsp;Michele Berrios,&nbsp;Judy Yee\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Computed tomography (CT) colonography's effectiveness, its associated patient advantages, and its potential role to increase colorectal cancer (CRC) screening rates have been demonstrated in previous research, but whether CT colonography has a cost advantage relative to optical colonoscopy for the commercially insured US population has not been assessed.</p><p><strong>Objective: </strong>To compare the costs of CRC screening using CT colonography or optical colonoscopy for commercially insured people in the United States.</p><p><strong>Methods: </strong>Using retrospective commercial healthcare claims data and peer-reviewed studies, we performed a simulated multiyear, matched-case comparison of the costs of CT and optical colonoscopies for CRC screening. We estimated commercial optical colonoscopy costs per screening based on the 2016 Truven Health MarketScan Commercial Database and ancillary services, such as bowel preparation, anesthesia, pathology, and complication costs. We developed 4 scenarios for CT colonography cost per screening using the ratio of commercial to Medicare fees, and calculated ancillary service and follow-up costs from payers' costs for these services when associated with optical colonoscopies. For comparison, we converted the costs per screening to the costs per screening year per person using real-world screening intervals that were obtained from peer-reviewed studies.</p><p><strong>Results: </strong>In 2016, the average optical colonoscopy screening cost for commercial payers was $2033 (N = 406,068), or $340 per screening year per person. With our highest-cost CT colonography scenario, CT colonography costs 22% less, or $265 per screening year, than optical colonoscopy, mostly because of the advantages for patients of no anesthesia and the greatly reduced use of pathology services.</p><p><strong>Conclusions: </strong>The use of CT colonography for CRC testing offers effective screening, patient-centered advantages, and lower costs compared with optical colonoscopy, and may be particularly appealing to the currently unscreened population with commercial health insurance. If the availability of CT colonography expands to meet the increased demand for it, CT colonography could cost up to 50% less than optical colonoscopy per screening year.</p>\",\"PeriodicalId\":48595,\"journal\":{\"name\":\"American Health and Drug Benefits\",\"volume\":\"11 7\",\"pages\":\"353-361\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2018-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306102/pdf/ahdb-11-353.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Health and Drug Benefits\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Health and Drug Benefits","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:计算机断层扫描(CT)结肠镜检查的有效性,其相关的患者优势,以及其增加结直肠癌(CRC)筛查率的潜在作用已在先前的研究中得到证实,但对于商业保险的美国人群,CT结肠镜检查是否具有相对于光学结肠镜检查的成本优势尚未得到评估。目的:比较美国商业保险人群使用CT结肠镜或光学结肠镜进行结直肠癌筛查的费用。方法:使用回顾性的商业医疗保健索赔数据和同行评审的研究,我们对CT和光学结肠镜用于CRC筛查的成本进行了模拟的多年匹配病例比较。我们根据2016年Truven Health MarketScan商业数据库和辅助服务(如肠道准备、麻醉、病理和并发症成本)估算了每次筛查的商业光学结肠镜检查成本。我们利用商业费用与医疗保险费用的比例,为每次筛查的CT结肠镜检查费用制定了4种方案,并计算了与光学结肠镜检查相关的辅助服务和随访费用。为了进行比较,我们使用从同行评议研究中获得的真实筛查间隔,将每次筛查的成本转换为每人每次筛查年的成本。结果:2016年,商业支付款人光学结肠镜筛查的平均费用为2033美元(N = 406068),即每人每筛查年340美元。在我们成本最高的CT结肠镜检查方案中,CT结肠镜检查的成本比光学结肠镜检查低22%,即每次筛查每年265美元,主要是因为对患者来说,无需麻醉和大大减少了病理服务的使用。结论:与光学结肠镜检查相比,使用CT结肠镜检查CRC提供了有效的筛查、以患者为中心的优势和更低的成本,可能对目前未接受筛查的有商业健康保险的人群特别有吸引力。如果CT结肠镜检查的可用性扩大以满足对其不断增长的需求,CT结肠镜检查每年的费用可能比光学结肠镜检查少50%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients.

Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients.

Background: Computed tomography (CT) colonography's effectiveness, its associated patient advantages, and its potential role to increase colorectal cancer (CRC) screening rates have been demonstrated in previous research, but whether CT colonography has a cost advantage relative to optical colonoscopy for the commercially insured US population has not been assessed.

Objective: To compare the costs of CRC screening using CT colonography or optical colonoscopy for commercially insured people in the United States.

Methods: Using retrospective commercial healthcare claims data and peer-reviewed studies, we performed a simulated multiyear, matched-case comparison of the costs of CT and optical colonoscopies for CRC screening. We estimated commercial optical colonoscopy costs per screening based on the 2016 Truven Health MarketScan Commercial Database and ancillary services, such as bowel preparation, anesthesia, pathology, and complication costs. We developed 4 scenarios for CT colonography cost per screening using the ratio of commercial to Medicare fees, and calculated ancillary service and follow-up costs from payers' costs for these services when associated with optical colonoscopies. For comparison, we converted the costs per screening to the costs per screening year per person using real-world screening intervals that were obtained from peer-reviewed studies.

Results: In 2016, the average optical colonoscopy screening cost for commercial payers was $2033 (N = 406,068), or $340 per screening year per person. With our highest-cost CT colonography scenario, CT colonography costs 22% less, or $265 per screening year, than optical colonoscopy, mostly because of the advantages for patients of no anesthesia and the greatly reduced use of pathology services.

Conclusions: The use of CT colonography for CRC testing offers effective screening, patient-centered advantages, and lower costs compared with optical colonoscopy, and may be particularly appealing to the currently unscreened population with commercial health insurance. If the availability of CT colonography expands to meet the increased demand for it, CT colonography could cost up to 50% less than optical colonoscopy per screening year.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Health and Drug Benefits
American Health and Drug Benefits Medicine-Health Policy
CiteScore
2.90
自引率
0.00%
发文量
4
期刊介绍: AHDB welcomes articles on clinical-, policy-, and business-related topics relevant to the integration of the forces in healthcare that affect the cost and quality of healthcare delivery, improve healthcare quality, and ultimately result in access to care, focusing on health organization structures and processes, health information, health policies, health and behavioral economics, as well as health technologies, products, and patient behaviors relevant to value-based quality of care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信